Organised by SHC

The Science of HBV Cure Meeting 2026 LIVE

For Scientists, Clinician Scientists and
Pharmacists and Industry Experts

4 – 5 September 2026

9.00am – 5.30pm (SGT)

The Science of HBV Cure Meeting 2026 LIVE

4 – 5 September 2026

9.00am – 5.30pm (SGT)

Register for Live Meeting

You will automatically be enrolled for SHC 2026 Online upon registration of the Science of HBV Cure Meeting 2026

You need to first Subscribe for Asian HBV/HDV Meeting 2026

Register Now

Who Should Attend?

The Science of HBV Cure Meeting is important for patients, doctors, scientists and pharmaceutical companies seeking to understand Hepatitis B and its new treatments. In particular, Hepatitis B cure is becoming a reality with new drugs tested in phase 3 clinical trials.

Additionally, Hepatitis D is also emerging as a disease for which therapy is rapidly evolving.   The Science of HBV Cure Meeting will also discuss the emerging treatments for HDV.

The Science of HBV Cure Meeting 2026 LIVE Scientific Programme
Full Programme currently in preparation

Call for Abstracts

Submission Deadline: 7 July 2026

We invite all interested parties to present their research papers. (abstracts of Case Studies will not be accepted) Click on below Abstracts and Posters for further information.

Abstracts will be reviewed by the Abstract Selection Committee and accepted submissions will be posted on Abstract & Poster Gallery in our website and in the Poster Hall. Presenters of oral presentations of accepted Abstracts as Free Papers will receive USD800 and a registration fee refund to help defray the cost of travel and accommodation here in Singapore.  This payment will be made after the presentation.

Only abstracts of research papers will be accepted. Abstracts of Case Studies will not be accepted.